Conditions: Chronic Thromboembolic Pulmonary Hypertension
Keywords: Chronic thromboembolic pulmonary hypertension (CTEPH)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 80
Healthy volunteers: no

Brief summary:
Study to evaluate if macitentan is efficient, safe and tolerable enough to be used for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH).

Detailed description:

Arms:
arm 1: Macitentan 10 mg, oral tablet, to be taken once daily. arm 2: Matching placebo oral tablet, to be taken once daily.

Interventions: intervention 1: Macitentan intervention 2: Placebo
Intervention descriptions: intervention 1: Macitentan 10 mg, oral tablet, to be taken once daily. intervention 2: Matching placebo oral tablet, to be taken once daily.

Protocol document: